Latest Schedule 13G passive stakes

Norges Bank has reported a beneficial ownership of 7.73% in Upstream Bio, Inc., holding 4,206,586 shares as of June 30, 2026.

Norges Bank has filed a Schedule 13G, reporting beneficial ownership of 5.5182% of Rogers Corp's common stock as of June 30, 2026.

Norges Bank has filed a Schedule 13G, reporting a beneficial ownership of 4.84% in New Oriental Education & Technology Group Inc. as of June 30, 2026.

Norges Bank reports a change in its beneficial ownership of Liberty Media Corp-Liberty Formula One common stock, now holding 5.5282% of the class.

Norges Bank has filed an amendment to its Schedule 13G, confirming its beneficial ownership of 2,337,471 shares, representing 2.01% of Kilroy Realty Corp.'s common stock as of June 30, 2026.

Norges Bank has reported a beneficial ownership of 5.46% in GMR Solutions Inc. common stock as of June 30, 2026.

Norges Bank has filed an amendment to its Schedule 13G, reporting a 6.4760% ownership stake in Federal Realty Investment Trust as of June 30, 2026.

Norges Bank has reported a beneficial ownership of 5.5676% in Digital Realty Trust, Inc. as of June 30, 2026, maintaining its position as a significant institutional investor.

Norges Bank has reported a beneficial ownership of 8.7955% in Celanese Corp's common stock as of June 30, 2026, holding 9,645,359 shares.

Norges Bank has reported beneficial ownership of 5.38% of Cabaletta Bio, Inc.'s common stock as of June 30, 2026, classifying itself as an investment adviser.

Norges Bank has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.0641% of BXP, Inc.'s common stock as of June 30, 2026.

Norges Bank has updated its beneficial ownership filing for Bilibili Inc., reporting a 6.7958% stake as of June 30, 2026.

Norges Bank has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 6.0636% in Atour Lifestyle Holdings Ltd.

Fosun International and its subsidiaries report a beneficial ownership stake of 4.7% in Chagee Holdings Ltd. Class A Ordinary Shares.

H.E.S.T. Australia Ltd. has reported beneficial ownership of 5.3% of EBR Systems, Inc. common stock, following a recent reverse stock split.

William Blair Investment Management, LLC has disclosed beneficial ownership of 5.6% of Revolve Group, Inc.'s common stock as of June 30, 2026.

William Blair Investment Management, LLC has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Twist Bioscience Corp. common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.2% of People Incorporated's common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.2% of People Incorporated's common stock as of June 30, 2026.

William Blair Investment Management, LLC has reported a complete divestment of its holdings in i3 Verticals, Inc., reducing its beneficial ownership to zero.

Yorkville International Capital Sponsor, LLC and affiliated entities report a combined beneficial ownership of 39.6% of Yorkville International Capital Corp.'s Class B Ordinary Shares, convertible to Class A.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting 0.00% beneficial ownership of Cantaloupe, Inc. common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting 0.00% beneficial ownership of Cantaloupe, Inc. common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.5% of Charlton Aria Acquisition Corp's Class A ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.5% of Charlton Aria Acquisition Corp's Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a 6.3% stake.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a 6.3% stake.

Harlan B. Korenvaes and Spruce Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 5.9% of MSC Industrial Direct Co Inc's Class A Common Stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.8% of Oceanhawk Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.8% of Oceanhawk Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.